Skip to content
Category: Press & Media
Inspirata AI Delivers Record Q2 with Five Major Academic Cancer Centers Selecting Its Native AI Platform

Inspirata AI Delivers Record Q2 with Five Major Academic Cancer Centers Selecting Its Native AI Platform

TAMPA, Fla., Aug 18, 2026 — Inspirata AI today announced a record-breaking second quarter, highlighted by five leading academic cancer…
Read More

Sign up to receive Press & Media updates

OSF HealthCare Cancer Registry E-Path Plus®

OSF HealthCare Selects Inspirata AI as Its Cancer Informatics Solution Provider

The new partnership between OSF HealthCare and Inspirata AI will see Inspirata AI’s data abstraction solution, E-Path Plus®, implemented by OSF.
Read More
Clinical Trials Guy's and St Thomas

Inspirata AI Partners with King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials

King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust will pilot Inspirata AI's Trial Navigator™.
Read More
Victorian Cancer Registry VCR

Inspirata AI Extends Multi-Year Partnership with the Victorian Cancer Registry

Inspirata AI announces a multi-year extension of its partnership with one of the world’s leading cancer registries, the Victorian Cancer Registry (VCR) in Australia.
Read More
Cord-19 NLP Inspirata

Inspirata AI Demonstrates How Its Clinically Optimized NLP Engine Excels in COVID-19 Disease Data Categorization and Other Healthcare Use Cases

Inspirata AI applied its Natural Language Processing (NLP) engine to help researchers extract clinical concepts that may be important for their projects on COVID-19. The company will hold a virtual
Read More
Inspirata Executive Exchange, Sapphire Falls Resort, July 31 - August 2, 2019

Inspirata AI Announces First Annual Executive Exchange Conference

Tampa, Florida, Jul 02, 2019 (GLOBE NEWSWIRE) –  Leading provider of tissue diagnostics and cancer care insight solutions, Inspirata AI, announced today its First Annual Executive Exchange, being held from July
Read More
AI-in-Medicine

Inspirata AI Acquires Toronto-Based Artificial Intelligence in Medicine, Inc. (AIM) to Enhance its R&D in Artificial Intelligence and Natural Language Processing

The strategic acquisition enhances Inspirata AI’s R&D capability in Artificial Intelligence and Natural Language Processing, enabling it to offer its clients advanced capabilities to extract cancer data from narrative text
Read More
Load More